App aims to keep brain tumor patients out of hospital
NCT ID NCT07439302
Summary
This study is testing a mobile app called Resilience PRO to see if it can help patients with a specific type of brain tumor (IDH-mutant glioma) better manage their symptoms and quality of life. The app will send weekly surveys to 80 patients to track their symptoms, fatigue, and mood. The goal is to see if this remote monitoring helps doctors catch problems early and improve patients' daily lives while they are on treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Neuro-oncologie, Hôpital de la Pitié-Salpêtrière
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.